Blog

Analysis & practitioner notes on Japan→Nasdaq
解説 / Analysis

Why Japanese microcaps fall after their Nasdaq debut

Listing is one thing; holding the price is another. Liquidity, float and the absence of IR — reading the lessons from the deals we track.

2026.06.12·編集部 / EditorialWRNTNCNCPCLAMRM
解説 / Analysis

The bookrunner pattern in Japan→Nasdaq deals: EF Hutton, Boustead, Kingswood

A handful of bookrunners recur across Japan's small-cap US listings. Reading the league table for who's actually doing these deals.

2026.06.08LREPXDTTOYOCTW
実務 / Practitioner

ADR vs direct listing (KK): choosing the structure for a Japanese issuer

ADR, Cayman reorg, KK direct listing, US-domestic S-1. The main structures a Japanese issuer chooses — with real examples.

2026.06.03MWCLGPSXHLDMTRS
実務 / Practitioner

What a US listing costs a Japanese issuer

From SEC registration fees to audit, legal and IR — decomposing what a US listing actually costs a Japanese issuer.

2026.05.28MRMSYTLRE
解説 / Analysis

Why Japanese companies are choosing Nasdaq

Thin domestic liquidity meets US institutional access. The structural case behind the Japan→Nasdaq migration.

2026.05.28MWCLAWR
解説 / Analysis

After the bell: a Japanese issuer's post-listing obligations

Listing isn't the finish line. 20-F/6-K, PCAOB audits, governance — the ongoing obligations of staying listed.

2026.05.22MRMPCLALRE
解説 / Analysis

Anatomy of the microcap IPO vendor stack

Bookrunner, auditor, US counsel, IR. Decomposing the vendor template Micware set and later deals copied.

2026.05.15MWCLREMRM
実務 / Practitioner

How to read an SEC comment letter

Post-filing comment cycles drive the timetable. Using a filed direct listing — Metros (MTRS) — to triage what actually matters.

2026.04.30MTRS
解説 / Analysis

Auditor choice can make or break a listing

PCAOB-registered capacity and inspection risk: how auditor selection shapes timetable and credibility.

2026.04.12MWCMRM